Pierre Massion
Faculty Member
Last active: 1/11/2018

Expression of focal adhesion kinase in small-cell lung carcinoma.

Ocak S, Chen H, Callison C, Gonzalez AL, Massion PP
Cancer. 2012 118 (5): 1293-301

PMID: 21800286 · PMCID: PMC3673887 · DOI:10.1002/cncr.26382

BACKGROUND - The focal adhesion kinase (FAK) is a non-receptor tyrosine kinase linked to tumor growth, invasion, and metastasis. FAK is overexpressed and associated with prognosis in many cancers, but its prognostic value in small-cell lung carcinoma (SCLC) is unknown and was the focus of this study.

METHODS - Total FAK expression was analyzed via immunohistochemistry in tissue microarrays consisting of formalin-fixed, paraffin-embedded SCLC specimens from 85 patients. FAK staining scores were tested for correlations with pathological characteristics and clinical outcomes. Phospho-paxillin was also tested in 35 of the 85 specimens to evaluate whether FAK expression was associated with downstream signaling.

RESULTS - Specific FAK expression was localized to the cytoplasm of 78/85 (92%) SCLCs. FAK expression was scored low in 11 (13%), moderate in 17 (20%), and high in 50 (59%) SCLCs. FAK staining scores treated as continuous variables did not correlate with SCLC disease stage, response to therapy, recurrence/progression-free survival, or overall survival. Moreover, total FAK expression did not correlate with phospho-paxillin Tyr(118) expression.

CONCLUSIONS - Total FAK is strongly expressed in a majority of SCLC tumors. However, the expression evaluated via immunohistochemistry is not a prognostic factor in patients with SCLC.

Copyright © 2011 American Cancer Society.

MeSH Terms (14)

Aged Female Focal Adhesion Kinase 1 Gene Expression Regulation, Enzymologic Gene Expression Regulation, Neoplastic Humans Lung Neoplasms Male Middle Aged Neoplasm Staging Paxillin Phosphorylation Small Cell Lung Carcinoma Survival Analysis

Connections (1)

This publication is referenced by other Labnodes entities: